Perceptive Advisors – ADAPTIMMUNE THERAPEUTICS

Perceptive Advisors ownership history of ADAPTIMMUNE THERAPEUTICS
QuarterValueSharesWeighting
Q4 2020$2,156
-32.5%
400,0000.0%0.02%
-51.1%
Q3 2020$3,192
-20.3%
400,0000.0%0.05%
-27.7%
Q2 2020$4,004
584.4%
400,000
711.3%
0.06%
333.3%
Q2 2018$58549,3020.02%